Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

GALLIUM GA 68 GOZETOTIDE

GALLIUM GA-68 GOZETOTIDE

Standard Dose
0.5-5mCi/mL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview GALLIUM GA 68 GOZETOTIDE is listed in Drugs@FDA under application 212643 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient GALLIUM GA-68 GOZETOTIDE Form and strength SOLUTION;INTRAVENOUS - 0.5-5mCi/mL Sponsor UNIV OF CA SAN FRAN Submission history Latest submission status date: 2022-06-16 00:00:00.

Structured Monograph

Clinical summary

Approval overview GALLIUM GA 68 GOZETOTIDE is listed in Drugs@FDA under application 212643 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient GALLIUM GA-68 GOZETOTIDE Form and strength SOLUTION;INTRAVENOUS - 0.5-5mCi/mL Sponsor UNIV OF CA SAN FRAN Submission history Latest submission status date: 2022-06-16 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
GALLIUM GA 68 GOZETOTIDE (GALLIUM GA-68 GOZETOTIDE) | Drug Monograph | MedicHelpline